We talk with Prof. Daniel Drucker about the early work on GLP-1 medicines for the treatment of diabetes, how they are now impacting the lives of people living with obesity, and their potential use for many other indications.
May 20, 2025•41 min•Ep. 19
Dr. Annegret Dahlmann-Noor explores why the number of children and adolescents with myopia is increasing and what we can do to halt the trend.
Apr 15, 2025•30 min•Ep. 18
Prof. Ali Mobasheri identifies the key issues in developing a successful DMOAD and how they can be overcome.
Mar 28, 2025•27 min•Ep. 17
Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.
Feb 27, 2025•30 min•Ep. 16
We talk to Dr. Cristina Saura about the concerns around breastfeeding after a breast cancer diagnosis, and why the POSITIVE results are such good news.
Jan 23, 2025•18 min•Ep. 15
Dr. Nicolas Villain outlines why it is so important to consider both clinical symptoms and biological findings when diagnosing Alzheimer's disease.
Dec 12, 2024•18 min•Ep. 14
Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
Aug 14, 2024•37 min•Ep. 13
Prof. Giacomo Grasselli takes us through the new concepts and explains why defining ARDS is such a difficult proposition.
Jul 05, 2024•16 min•Ep. 12
Dr. Eduard Shantsila discusses rehabilitation approaches for complex patients with heart disease and comorbid frailty, including those with cognitive vulnerability.
May 24, 2024•19 min•Ep. 11
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Feb 29, 2024•35 min•Ep. 10
Prof. Marion Subklewe explores the interplay between the gut microbiota and the efficacy and safety of CAR T-cell therapy in people with hematologic malignancies.
Feb 14, 2024•20 min•Ep. 9
Prof. Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists in predicting patients’ clinical outcomes after stroke.
Jan 03, 2024•15 min•Ep. 8
A conversation with Dr. Luis Paz-Ares about the key questions raised by the ADAURA trial of adjuvant osimertinib in early-stage NSCLC.
Dec 06, 2023•18 min•Ep. 7
Drs Niels Holm and Lene Andreasen explore the latest data on OCT and discuss its potential as an effective approach in PCI.
Oct 16, 2023•19 min•Ep. 6
Professor Andrew Beggs discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers. This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company
Sep 21, 2023•25 min•Ep. 5
Prof. Malin Parmar explains why stem cell therapy is such a good option for patients with Parkinson’s disease and how its safety is being tested in the STEM-PD trial.
Aug 14, 2023•18 min•Ep. 4
Professors Morris Brown and Bryan Williams join Jane Godsland to explore the theories behind resistant hypertension, and the latest treatment approaches.
Jul 07, 2023•23 min•Ep. 3
We speak to Dr. Elena Castro about the latest data on PARP inhibitors in prostate cancer as presented at this year's ASCO Genitourinary Cancers Symposium.
Jun 01, 2023•23 min•Ep. 2
We talk to Dr. Nathalie van Havre and Dr. Elsbeth Headley about ongoing medical education in the digital age.
Apr 18, 2023•31 min•Ep. 1
Dr. Jane Godsland & Dr. Erik Heintz discuss the vision for Springer Medicine and offer some teasers for what's to come.
Feb 20, 2023•12 min•Ep. 1
